570 Biowissenschaften; Biologie
Refine
Departments, institutes and facilities
- Institut für funktionale Gen-Analytik (IFGA) (160)
- Fachbereich Angewandte Naturwissenschaften (122)
- Institut für Technik, Ressourcenschonung und Energieeffizienz (TREE) (30)
- Graduierteninstitut (5)
- Fachbereich Informatik (2)
- Fachbereich Wirtschaftswissenschaften (2)
- Institut für Sicherheitsforschung (ISF) (2)
- Fachbereich Ingenieurwissenschaften und Kommunikation (1)
- Internationales Zentrum für Nachhaltige Entwicklung (IZNE) (1)
- Zentrum für Wissenschafts- und Technologietransfer (ZWT) (1)
Document Type
- Article (221)
- Part of a Book (12)
- Doctoral Thesis (8)
- Conference Object (6)
- Preprint (3)
- Report (1)
Year of publication
Keywords
- ENaC (10)
- stem cells (6)
- Lignin (5)
- drug release (5)
- DNA methylation (4)
- Gene expression (4)
- Inborn error of metabolism (4)
- Organic aciduria (4)
- lignin (4)
- osteogenesis (4)
- scaffolds (4)
- 5-Methylcytosine (3)
- Amiloride (3)
- Glycine conjugation (3)
- Isovaleric acidemia (3)
- Metabolic acidosis (3)
- Na+/K+-ATPase (3)
- additive (3)
- angiogenesis (3)
- antioxidant (3)
- biomass (3)
- bone tissue engineering (3)
- hydrogel (3)
- organosolv (3)
- Additiv (2)
- Biomass (2)
- Capillary electrophoresis – laser-induced fluorescence (2)
- DNA adducts (2)
- Epithelial Na+ channel (2)
- Epithelial sodium channel (2)
- Folin-Ciocalteu assay (2)
- Glycine N-acyltransferase (2)
- H2S (2)
- Ketogenesis (2)
- Ketolysis (2)
- Ketone body (2)
- Mars (2)
- Mass spectrometry (2)
- Mesenchymal stem cells (2)
- Miscanthus x giganteus (2)
- NF-κB (2)
- Osteogenesis (2)
- Regenerative medicine (2)
- Scaffolds (2)
- Stem cells (2)
- Thyme (2)
- Thymian (2)
- acetylcholine (2)
- antioxidant activity (2)
- biomaterial (2)
- bone regeneration (2)
- cystic fibrosis (2)
- cytokine-induced killer cells (2)
- delta-subunit (2)
- endocytosis (2)
- epithelial sodium channel (ENaC) (2)
- extremophile (2)
- extremophiles (2)
- force generation (2)
- gasotransmitter (2)
- hydrogen sulfide (2)
- hypoxia (2)
- immunotherapy (2)
- lignocellulose feedstock (2)
- melanin (2)
- migration (2)
- monolignol ratio (2)
- mucociliary clearance (2)
- multivariate data processing (2)
- myosin (2)
- polyphenols (2)
- sodium channel (2)
- sodium self-inhibition (2)
- sodium transport (2)
- tissue engineering (2)
- total phenol content (2)
- 1H (1)
- 5-HT (1)
- ACAT1 (1)
- ADA2 (1)
- ADP release (1)
- APC superfamily (1)
- ATB0,+ (1)
- ATPase cycle (1)
- Activity-based probes (1)
- Acylpeptide hydrolase (1)
- Additive (1)
- Adipogenesis (1)
- Adipose tissue (1)
- Adipose tissue-derived stem cells (1)
- Affinity proteomics (1)
- Airway surface liquid (1)
- Algorithms (1)
- Allicin (1)
- Amino Acid Sequence (1)
- Aminoacylase (1)
- Anionic surfactant (1)
- Antarctic ice sheet (1)
- Antibodies* (1)
- Antibody analysis (1)
- Antigen analysis (1)
- Antimicrobial activity (1)
- Antioxidans (1)
- Antioxidant activity (1)
- Antioxidant capacity (1)
- Antioxidative Capacity (1)
- Antioxidatives Potential (1)
- Assay development (1)
- Assay reproducibility (1)
- Asymmetric cell division (1)
- Automated multiple development (1)
- B cells (1)
- B-cell leukemia (1)
- BLAST (1)
- Bacillus (1)
- Bactericidal effect (1)
- BcL-2 family (1)
- Behcet’s Disease (1)
- Benzoyl-coenzym A (1)
- Benzyl alkyl ammonium chloride (1)
- Beta-ketothiolase (1)
- Bioactive (1)
- Bioaktiv (1)
- Biomarkers stability (1)
- Biomaterial (1)
- Biomineralisation (1)
- Biomineralization (1)
- Biopolymers (1)
- Biorefinery (1)
- Biosignatures (1)
- Black soldier fly larva (1)
- Block copolymer (1)
- Bone (1)
- Bone marrow-derived stem cells (1)
- CD21 (1)
- CE-LIF (1)
- CFTR (1)
- CHRNA (1)
- CLL (1)
- CO (1)
- Calcium (1)
- Calcium Intracellular Release (1)
- Capillary electrophoresis (1)
- Carbapenem (1)
- Cardiovascular Disease (1)
- Cationic surfactant (1)
- Cell Cycle (1)
- Cell Differentiation (1)
- Cell Signaling (1)
- Cell activation (1)
- Cell lineage (1)
- Cellulose (1)
- Ceramides (1)
- Charakterisierung (1)
- Chemometrics (1)
- Cholesterol (1)
- Christmas trees (1)
- Chronic lymphocytic leukemia (1)
- Collagen (1)
- Complement receptor (1)
- Composites (1)
- Comprehensive two-dimensional liquid chromatography (1)
- Computer Graphics (1)
- Confocal microscopy (1)
- Coumarins (1)
- Cysteine proteases (1)
- DADA2 (1)
- DEG/ENaC family (1)
- DNA (1)
- DNA Transcription (1)
- DNA damage (1)
- DNA interaction (1)
- DOSY (1)
- Daptomycin (1)
- Database Management Systems (1)
- Databases, Factual (1)
- Deficiency of ADA2 (1)
- Dehydrogenase (1)
- Delta-ENaC (1)
- Dental follicle (1)
- Development (1)
- Diabetes (1)
- Diselenide bridge (1)
- Docking (1)
- Dried serum spots (1)
- Drosophila (1)
- EPHB2 (1)
- ESKAPEE pathogens (1)
- ETV6-RUNX1 (1)
- Echinoderms (1)
- Endosomes (1)
- Enhancer (1)
- Enzyme activity (1)
- Epigenomics (1)
- Epithelial-mesenchymal transition (1)
- Epitope mapping: Epitope extraction (1)
- Esterquat (1)
- European horse chestnut (1)
- Evans blue (1)
- ExoMars (1)
- Exome sequencing (1)
- FOXA1 (1)
- Fatty acid metabolism (1)
- Fatty acids (1)
- Fatty alcohol alkoxylate (1)
- Fatty alcohol alkoxylates (1)
- Food allergy (1)
- GC × GC (1)
- GC×GC (1)
- GLYCTK (1)
- GMX1778 (1)
- Galactic Cosmic Rays (GCRs) (1)
- Garlic (1)
- Genes (1)
- Genomics (1)
- Genomics/methods (1)
- Genregulation (1)
- Glutamin N-phenylacetyltransferase (1)
- Glycin N-acyltransferase (1)
- Glycine N-Acyltransferase (GLYAT) (1)
- Glycopeptides (1)
- Glyzinkonjugation (1)
- Growth (1)
- HILIC (1)
- HMGCL (1)
- HPTLC (1)
- HSD10 (1)
- HSP90 (1)
- HSQC NMR (1)
- Harnstoffzyklusdefekt (1)
- Heparin (1)
- Hermetia illucens (1)
- Hierarchical Framework (1)
- Histamine (1)
- Histamine receptors (1)
- Homeobox (1)
- Hyperammonemia (1)
- Hypoglycemia (1)
- IR microspectroscopy (1)
- Immunology* (1)
- In silico epitope prediction (1)
- Intracellular Ca2+ (1)
- Ionizing radiation (1)
- Isoleucine (1)
- Isovalerianazidämie (1)
- Ketoacidosis (1)
- Ketone body synthesis (1)
- Ketone body utilization (1)
- Krebsforschung (1)
- LCxLC-MS (1)
- LEF1 (1)
- LET (1)
- Laser-induced fluorescence (1)
- LeuT (1)
- Leucine (1)
- Leucine degradation (1)
- Ligand -Receptor Interactions* (1)
- Lightweight Design (1)
- Lignocellulose feedstock (1)
- Linezolid (1)
- Lipoaspirate (1)
- Lysosomes (1)
- MPV17 monoclonal antibody (1)
- MRPP (1)
- MYB (1)
- Malus domestica (1)
- Marbled crayfish (1)
- Mars environment (1)
- Mars exploration (1)
- Mast cells (1)
- Mechanosensitive (1)
- Membrane Transport (1)
- Mesenchymal stromal cells (1)
- Metabolic decompensation (1)
- Metabolicdecompensation (1)
- Methylation (1)
- Methyltransferase (1)
- Miscanthus nagara (1)
- Miscanthus robustus (1)
- Miscanthus sinensis (1)
- Mitochondria (1)
- Mitochondrial DNA depletion syndrome (1)
- Mitochondrial apoptogens (1)
- Mitochondrial outer membrane permeabilization (MOMP) (1)
- Mitochondrial tRNA (1)
- Molecular Sequence Data (1)
- Molecular dynamics (1)
- Molecular weight (1)
- Morphology Symmetry (1)
- Multilineage potential (1)
- Mxi-2 (1)
- N-isovalerylglycine (1)
- NMR (1)
- NMR spectroscopy (1)
- NO (1)
- NSS family (1)
- Na+ absorption (1)
- Na+/K+ ATPase (1)
- Nadelhölzer (1)
- Nanoparticles (1)
- Non-covalent interaction MS* (1)
- OXCT1 (1)
- Organic acids (1)
- Osteogenic differentiation (1)
- Oxidative stress (1)
- P1 receptor (1)
- P2 receptor (1)
- PD-1/CTLA-4 (1)
- PLS-regression (1)
- PTHrP (1)
- Partial least squares regression (1)
- Patient serum (1)
- Patterning (1)
- Peroxisomes (1)
- Pharmacogenetics (1)
- Phase II Reaktion (1)
- Phase II reaction (1)
- Phenylacetyl-coenzym A (1)
- Pleiotropic drug resistance (1)
- Polymorphism (1)
- Polysaccharide derivatives (1)
- Pre-punched filter paper discs (1)
- Programmed cell death (1)
- Promoter methylation (1)
- Proteasome maturation (1)
- Protein Conformation (1)
- Protein Folding (1)
- Protein complex analysis (1)
- Proteins/chemistry (1)
- Proteome analysis (1)
- Pulmonary epithelium (1)
- Pulping (1)
- Purinergic signaling (1)
- RAID (1)
- RELA (1)
- RELA haploinsufficiency (1)
- RELA-associated inflammatory disease (1)
- Raman and FTIR spectroscopies (1)
- Random copolymer (1)
- Redox potential (1)
- Regeneration (1)
- Renewable resource (1)
- Ressource (1)
- RhoA GTPases (1)
- Rosskastanie (1)
- SERS (1)
- SLC (1)
- SLC6 (1)
- SLC6A14 (1)
- STARLIFE project (1)
- STF-31 (1)
- Saccharomyces cerevisiae (1)
- Schneeglöckchen (1)
- Selenocysteine (1)
- Self-assembling (1)
- Sequence Homology, Amino Acid (1)
- Serine proteases (1)
- Shear force (1)
- Skeletal Structures (1)
- Splicing (1)
- Stabilisator (1)
- Stabilization (1)
- Stereom (1)
- Stratum corneum lipids (1)
- Submerge and dry protocol (1)
- Submucosal plexus (1)
- Substrate mapping (1)
- Surfactants (1)
- Synergie (1)
- TEL-AML1 (1)
- TNF inhibitors (1)
- Targeted mass spectrometry (1)
- Template-mediation (1)
- Tetramerisation (1)
- Therapeutic antibodies* (1)
- Time–kill methodology (1)
- Tissue engineering (1)
- Transcription Regulation (1)
- Transcriptional enhancer (1)
- Translocation (1)
- UV (1)
- UV Absorption (1)
- UV absorbance (1)
- UV spectrum (1)
- UV-Absorption (1)
- UV-vis spectroscopy (1)
- Ultrastructure (1)
- Urea cycle defect (1)
- User-Computer Interface (1)
- Valproic acid (1)
- Vascular Smooth Muscle Cells (1)
- Vim3 (1)
- WZB117 (1)
- Weihnachtsbaum (1)
- Xenopus (1)
- Xenopus laevis (1)
- Xenopus oocyte (1)
- Yersinia toxins (1)
- ZAP-70 (1)
- accelerated iron ions (1)
- acidic ethanosolv (1)
- actin (1)
- acute respiratory distress syndrome (1)
- agarose (1)
- aging (1)
- air-blood barrier (1)
- airway (1)
- airway rehydration (1)
- airway smooth muscle (1)
- albuminuria (1)
- allosteric communication (1)
- allosteric regulation (1)
- alveolar epithelium (1)
- alveolar fluid (1)
- alveolar fluid transport (1)
- alveoli (1)
- amelogenesis (1)
- amino acid transport (1)
- amino acid transporter (1)
- anti-TNF (1)
- apoptosis (1)
- astrobiology (1)
- atopy (1)
- autohydrolysis (1)
- autoimmunity (1)
- autoinflammation (1)
- autoinflammatory (1)
- autoinflammatory diseases (1)
- automated electrophysiology (1)
- bdelloid rotifer (1)
- behavior (1)
- benchtop (1)
- benzoyl-coA (1)
- bio-based (1)
- biobasiert (1)
- biochemical fingerprinting (1)
- biocomposite (1)
- biofilm removal (1)
- biofilm-related infections (1)
- biomolecules (1)
- bio‐based (1)
- black fungi (1)
- blebbistatin (1)
- blown film (1)
- bone (1)
- bone marrow failure (1)
- brain (1)
- breathing (1)
- bronchus (1)
- brush cells (1)
- cancer (1)
- carbon monoxide (1)
- carbon monoxide-releasing molecule (1)
- carbon sequestration (1)
- caspase (1)
- caveolin-1 (1)
- cell harvesting (1)
- cell migration (1)
- cementogenesis (1)
- chain extending cross-linker (1)
- characterization (1)
- chemometrics (1)
- chemosensory cells (1)
- cholinergic (1)
- chromatin remodeling (1)
- chymotrypsin (1)
- clinical study (1)
- composites (1)
- condensation (1)
- coniferous woods (1)
- contraction (1)
- cosmic rays (1)
- cytoskeleton (1)
- d-Glycerate kinase deficiency (1)
- d-Glyceric aciduria (1)
- data base search (1)
- deficiency of adenosine deaminase 2 (1)
- degree of disintegration (1)
- dental stem cells (1)
- dental stem cells immortalization (1)
- dentinogenesis (1)
- dentogenesis (1)
- depolymerization (1)
- differentiation (1)
- disintegration kinetics (1)
- drug release materials (1)
- duty ratio (1)
- dynamin (1)
- electrolyte transport (1)
- electrophysiology (1)
- endothelial cell differentiation (1)
- endothelial cells (1)
- enhanced weathering (1)
- enzyme activity (1)
- epilepsy (1)
- epithelial sodium channels (1)
- epithelial transport (1)
- epitope mapping (1)
- evolution (1)
- extraction (1)
- extraterrestrial analogue (1)
- familial Mediterranean fever (1)
- fasentin (1)
- fatty acid metabolism (1)
- feeding regulation (1)
- food contact material (1)
- formulation (1)
- four-ply (1)
- fungal and bacterial amplicon sequencing (1)
- fungi (1)
- furin (1)
- gas exchange (1)
- genome sequencing (1)
- genotype (1)
- genotype-phenotype correlations (1)
- glucose uptake inhibitor (1)
- glutamine N-phenylacetyltransferase (1)
- glycerophosphocholine (1)
- greenhouse gas emissions (1)
- growth factors (1)
- habitability (1)
- healthcare-associated infections (HAI) (1)
- heavy ion particle (HZE) radations (1)
- hematopoietic stem cell transplantation (1)
- horse chestnut (1)
- hydroxyapatite (1)
- hypertension (1)
- iPSCs (1)
- immunodeficiency (1)
- infection prevention (1)
- inflammasome (1)
- inhibitor (1)
- insertion (1)
- insulin/IGF-1 signaling (1)
- interleukin-1beta (1)
- ketogenesis (1)
- ketone body synthesis (1)
- kraft lignin (1)
- leucine degradation (1)
- life detection (1)
- life on Mars (1)
- life-detection (1)
- lignin structure analysis (1)
- longevity regulation (1)
- loss-of-function variants (1)
- low-input crops (1)
- low-level laser therapy (1)
- lung (1)
- lung liquid clearance (1)
- lymphoma (1)
- lysophosphatidylcholine (1)
- mTOR (1)
- macrophages. (1)
- manure (1)
- mesenchymal stem cell (1)
- mesenchymal stem cells (1)
- metabolic integration (1)
- metabolically active cells (1)
- metabolism (1)
- miR-15 (1)
- miR-498 (1)
- microcephaly (1)
- molecular docking (1)
- molecular dynamics simulations (1)
- molecular evolution (1)
- molecular mass degradation (1)
- molecular motor (1)
- molecular weight determination (1)
- molecule-surface interactions (1)
- monoclonal antibody (1)
- mucosal ulcers (1)
- multi-drug response (1)
- muscarine (1)
- myogenesis (1)
- nachhaltig (1)
- nanomaterials (1)
- nanostructured surfaces (1)
- negative emissions (1)
- neuroendocrine (1)
- neuroendocrine system (1)
- nicotine and phosphocholine (1)
- nitric oxide (1)
- non-apoptotic roles (1)
- nosocomial infections (1)
- nucleic acids (1)
- nutrient germinants (1)
- nutrient signaling (1)
- odontogenic cells (1)
- organic acid analysis (1)
- organic aciduria (1)
- organoids (1)
- organosolv lignin (1)
- osteoblast (1)
- osteoclast (1)
- outside-out (1)
- pH (1)
- panspermia (1)
- patch clamp (1)
- patch-clamp (1)
- patent (1)
- pathogen control (1)
- peptide sequencing (1)
- phase II reaction (1)
- phenylacetyl-coA (1)
- photostabiliser (1)
- physiology (1)
- pigments (1)
- planetary protection (1)
- poly(butylene adipate terephthalate) (1)
- poly(lactic acid) (1)
- polysaccharide (1)
- power stroke (1)
- principal component analysis (1)
- proanthocyanidins (1)
- probiotic cleaning (1)
- probiotic-based cleaning formulations (1)
- process parameters (1)
- proliferation (1)
- protease (1)
- protein microarray (1)
- proteomics (1)
- prototype apparatus (1)
- proximal tubule (1)
- pure red cell aplasia (1)
- purinergic receptor (1)
- purinergic receptors (1)
- pyrin inflammasome (1)
- quantitative RP-HPLC-DAD (1)
- quantitative RT-PCR (1)
- radiation (1)
- radioresistance (1)
- regenerative medicine (1)
- renal cancer (1)
- resistance (1)
- ressources (1)
- salt (1)
- scaffold (1)
- scratch assay (1)
- seed coat (1)
- self-assembled monolayers (1)
- serine-threonine kinase (1)
- serum and glucocorticoid-induced kinase 1 (1)
- single-cell RNA-seq (1)
- size exclusion chromatography (1)
- smooth muscle cell differentiation (1)
- snowdrop (1)
- sodium absorption (1)
- sodium/potassium-exchanging ATPase (1)
- soil biota (1)
- soil sickness (1)
- solute carrier (1)
- space radiation environment (1)
- spore resistance (1)
- sporegermination (1)
- stabilisation (1)
- stem cell niche (1)
- structural biology (1)
- structure prediction (1)
- surface sanitization (1)
- surfaces (1)
- survival (1)
- sustainable (1)
- symbiosis (1)
- synergism (1)
- synergistic effect (1)
- systemic response (1)
- tRNA processing (1)
- taste (1)
- tetrapod (1)
- thermophoresis (1)
- three-ply (1)
- transcriptional regulation (1)
- transient kinetics (1)
- transporter (1)
- triiodothyronine (1)
- two-electrode voltage clamp (1)
- ubiquitination (1)
- urea cycle defect (1)
- urethra (1)
- urethral brush cells (1)
- vasculitis (1)
- voltage-independent Na+ channel (1)
- waste water treatment (1)
- water-to-land transition (1)
- whole-tooth regeneration (1)
- wound healing assay (1)
The human gut microbiota harbors untapped potential for biotechnological applications. Within the phylum of Bacteroidota, Phocaeicola vulgatus stands out as a promising candidate for sustainable production of key platform chemicals like succinate. However, genetic engineering of Phocaeicola sp. remains challenging due to its intricate molecular landscape. This study lays the groundwork for manipulating the central carbon pathways in Phocaeicola vulgatus, offering insights into overcoming genetic hurdles for increased succinate yields.
Striated muscle contraction is regulated by the translocation of troponin-tropomyosin strands over the thin filament surface. Relaxation relies partly on highly-favorable, conformation-dependent electrostatic contacts between actin and tropomyosin, which position tropomyosin such that it impedes actomyosin associations. Impaired relaxation and hypercontractile properties are hallmarks of various muscle disorders. The α-cardiac actin M305L hypertrophic cardiomyopathy-causing mutation lies near residues that help confine tropomyosin to an inhibitory position along thin filaments. Here, we investigate M305L actin in vivo, in vitro, and in silico to resolve emergent pathological properties and disease mechanisms. Our data suggest the mutation reduces actin flexibility and distorts the actin-tropomyosin electrostatic energy landscape that, in muscle, result in aberrant contractile inhibition and excessive force. Thus, actin flexibility may be required to establish and maintain interfacial contacts with tropomyosin as well as facilitate its movement over distinct actin surface features and is, therefore, likely necessary for proper regulation of contraction.
In memoriam Willy Lehnert
(2023)
RELA haploinsufficiency is a recently described autoinflammatory condition presenting with intermittent fevers and mucocutaneous ulcerations. The RELA gene encodes the p65 protein, one of five NF-κB family transcription factors. As RELA is an essential regulator of mucosal homeostasis, haploinsufficiency leads to decreased NF-κB signaling which promotes TNF-driven mucosal apoptosis with impaired epithelial recovery. Thus far, only eight cases have been reported in the literature. Here, we report four families with three novel and one previously described pathogenic variant in RELA. These four families included 23 affected individuals for which genetic testing was available in 16. Almost half of these patients had been previously diagnosed with more common rheumatologic entities (such as Behcet's Disease; BD) prior to the discovery of their pathogenic RELA variants. The most common clinical features were orogenital ulcers, rash, joint inflammation, and fever. The least common were conjunctivitis and recurrent infections. Clinical variability was remarkable even among familial cases, and incomplete penetrance was observed. Patients in our series were treated with a variety of medications, and benefit was observed with glucocorticoids, colchicine, and TNF inhibitors. Altogether, our work adds to the current literature and doubles the number of reported cases with RELA-Associated Inflammatory Disease (RAID). It reaffirms the central importance of the NF-κB pathway in immunity and inflammation, as well as the important regulatory role of RELA in mucosal homeostasis. RELA associated inflammatory disease should be considered in all patients with BD, particularly those with early onset and/or with a strong family history.
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo racemosa, and polyarteritis nodosa in 2014. It is now recognized that patients may develop multisystem disease that spans multiple medical subspecialties. Here, we describe the findings from a large single center longitudinal cohort of 60 patients, the broad phenotypic presentation, as well as highlight the cohort's experience with hematopoietic cell transplantation and COVID-19. Disease manifestations could be separated into three major phenotypes: inflammatory/vascular, immune dysregulatory, and hematologic, however, most patients presented with significant overlap between these three phenotype groups. The cardinal features of the inflammatory/vascular group included cutaneous manifestations and stroke. Evidence of immune dysregulation was commonly observed, including hypogammaglobulinemia, absent to low class-switched memory B cells, and inadequate response to vaccination. Despite these findings, infectious complications were exceedingly rare in this cohort. Hematologic findings including pure red cell aplasia (PRCA), immune-mediated neutropenia, and pancytopenia were observed in half of patients. We significantly extended our experience using anti-TNF agents, with no strokes observed in 2026 patient months on TNF inhibitors. Meanwhile, hematologic and immune features had a more varied response to anti-TNF therapy. Six patients received a total of 10 allogeneic hematopoietic cell transplant (HCT) procedures, with secondary graft failure necessitating repeat HCTs in three patients, as well as unplanned donor cell infusions to avoid graft rejection. All transplanted patients had been on anti-TNF agents prior to HCT and received varying degrees of reduced-intensity or non-myeloablative conditioning. All transplanted patients are still alive and have discontinued anti-TNF therapy. The long-term follow up afforded by this large single-center study underscores the clinical heterogeneity of DADA2 and the potential for phenotypes to evolve in any individual patient.
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
(2021)
BACKGROUND
Biallelic loss-of-function variants in NCF1 lead to reactive oxygen species deficiency and chronic granulomatous disease (CGD). Heterozygosity for the p.Arg90His variant in NCF1 has been associated with susceptibility to systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome in adult patients. This study demonstrates the association of the homozygous p.Arg90His variant with interferonopathy with features of autoinflammation and autoimmunity in a pediatric patient.
CASE PRESENTATION
A 5-year old female of Indian ancestry with early-onset recurrent fever and headache, and persistently elevated antinuclear, anti-Ro, and anti-La antibodies was found to carry the homozygous p.Arg90His variant in NCF1 through exome sequencing. Her unaffected parents and three other siblings were carriers for the mutant allele. Because the presence of two NCF1 pseudogenes, this variant was confirmed by independent genotyping methods. Her intracellular neutrophil oxidative burst and NCF1 expression levels were normal, and no clinical features of CGD were apparent. Gene expression analysis in peripheral blood detected an interferon gene expression signature, which was further supported by cytokine analyses of supernatants of cultured patient's cells. These findings suggested that her inflammatory disease is at least in part mediated by type I interferons. While her fever episodes responded well to systemic steroids, treatment with the JAK inhibitor tofacitinib resulted in decreased serum ferritin levels and reduced frequency of fevers.
CONCLUSION
Homozygosity for p.Arg90His in NCF1 should be considered contributory in young patients with an atypical systemic inflammatory antecedent phenotype that may evolve into autoimmunity later in life. The complex genomic organization of NCF1 poses a difficulty for high-throughput genotyping techniques and variants in this gene should be carefully evaluated when using the next generation and Sanger sequencing technologies. The p.Arg90His variant is found at a variable allele frequency in different populations, and is higher in people of South East Asian ancestry. In complex genetic diseases such as SLE, other rare and common susceptibility alleles might be necessary for the full disease expressivity.
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL), defined primarily by developmental delay/intellectual disability, speech delay, postnatal microcephaly, and dysmorphic features, is a syndrome resulting from heterozygous variants in the dosage-sensitive bromodomain PHD finger chromatin remodeler transcription factor BPTF gene. To date, only 11 individuals with NEDDFL due to de novo BPTF variants have been described. To expand the NEDDFL phenotypic spectrum, we describe the clinical features in 25 novel individuals with 20 distinct, clinically relevant variants in BPTF, including four individuals with inherited changes in BPTF. In addition to the previously described features, individuals in this cohort exhibited mild brain abnormalities, seizures, scoliosis, and a variety of ophthalmologic complications. These results further support the broad and multi-faceted complications due to haploinsufficiency of BPTF.
Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation
(2020)
Systemic autoinflammatory diseases (SAIDs) are a group of inflammatory disorders caused by dysregulation in the innate immune system that leads to enhanced immune responses. The clinical diagnosis of SAIDs can be difficult since individually these are rare diseases with considerable phenotypic overlap. Most SAIDs have a strong genetic background, but environmental and epigenetic influences can modulate the clinical phenotype. Molecular diagnosis has become essential for confirmation of clinical diagnosis. To date there are over 30 genes and a variety of modes of inheritance that have been associated with monogenic SAIDs. Mutations in the same gene can lead to very distinct phenotypes and can have different inheritance patterns. In addition, somatic mutations have been reported in several of these conditions. New genetic testing methods and databases are being developed to facilitate the molecular diagnosis of SAIDs, which is of major importance for treatment, prognosis and genetic counselling. The aim of this review is to summarize the latest advances in genetic testing for SAIDs and discuss potential obstacles that might arise during the molecular diagnosis of SAIDs.
The pyrin inflammasome has evolved as an innate immune sensor to detect bacterial toxin-induced Rho guanosine triphosphatase (Rho GTPase)-inactivation, a process that is similar to the "guard" mechanism in plants. Rho GTPases act as molecular switches to regulate a variety of signal transduction pathways including cytoskeletal organization. Pathogens can modulate Rho GTPase activity to suppress host immune responses such as phagocytosis. Pyrin is encoded by MEFV, the gene that is mutated in patients with familial Mediterranean fever (FMF). FMF is the prototypic autoinflammatory disease characterized by recurring short episodes of systemic inflammation and is a common disorder in many populations in the Mediterranean basin. Pyrin specifically senses modifications in the activity of the small GTPase RhoA, which binds to many effector proteins including the serine/threonine-protein kinases PKN1 and PKN2 and actin-binding proteins. RhoA activation leads to PKN-mediated phosphorylation-dependent pyrin inhibition. Conversely, pathogen virulence factors downregulate RhoA activity in a variety of ways, and these changes are detected by the pyrin inflammasome irrespective of the type of modifications. MEFV pathogenic variants favor the active state of pyrin and elicit proinflammatory cytokine release and pyroptosis. They can be inherited either as a dominant or recessive trait depending on the variant's location and effect on the protein function. Mutations in the C-terminal B30.2 domain are usually considered recessive, although heterozygotes may manifest a biochemical or even a clinical phenotype. These variants are hypomorphic in regard to their effect on intramolecular interactions, but ultimately accentuate pyrin activity. Heterozygous mutations in other domains of pyrin affect residues critical for inhibition or protein oligomerization, and lead to constitutively active inflammasome. In healthy carriers of FMF mutations who have the subclinical inflammatory phenotype, the increased activity of pyrin might have been protective against endemic infections over human history. This finding is supported by the observation of high carrier frequencies of FMF-mutations in multiple populations. The pyrin inflammasome also plays a role in mediating inflammation in other autoinflammatory diseases linked to dysregulation in the actin polymerization pathway. Therefore, the assembly of the pyrin inflammasome is initiated in response to fluctuations in cytoplasmic homeostasis and perturbations in cytoskeletal dynamics.
The generation and maintenance of intricate spatiotemporal patterns of gene expression in multicellular organisms requires the establishment of complex mechanisms of transcriptional regulation. Estimations that up to one million enhancers exist in the human genome accentuates the utmost importance of this type of cis-regulatory element for gene regulation. However, surprisingly little is known about the mechanisms used to temporarily or permanently activate or inactivate enhancers during cellular differentiation. The current work addresses the question how enhancer regulation can be achieved.
Using the chemokine (C-C motif) ligand gene Ccl22 as a model, the first example is based on the question how the activation of an enhancer can be prevented in a physiological context. Ccl22 is expressed by myeloid cells, such as dendritic cells, upon exposure to inflammatory stimuli. The expression in other cell types, such as fibroblasts, is prevented by the strong accumulation of H3K9me3 at the enhancer's proximal region. This accumulation is attenuated in myeloid cells through activity of the stimulus-induced demethylase Jmjd2d. To tease out which genomic fragment or fragments in the Ccl22 locus could be responsible for the maintenance of enhancer inactivity, potentially through the recruitment of H3K9 methyltransferases, the enhancer repressing capacity of 1 kb fragments of the gene locus was analysed in retroviral reporter assays. It was found that a fragment adjacent to the Ccl22 enhancer that overlaps with a member of a subfamily of long interspersed nuclear elements (LINEs) showed strong repressive potential on a model enhancer. Subsequent retroviral reporter assays with LINEs from loci of other stimulus-dependent genes identified additional LINE fragments that exhibit strong enhancer repressive capacity. These findings suggest a mechanism for enhancer silencing involving LINEs.
The second example concentrates on the inactivation of an enhancer during colorectal cancer (CRC) progression. The adenoma to carcinoma transition during CRC progression often is accompanied by a downregulation of the tumour suppressor gene EPHB2. The EMT inducing factor SNAIL1 strongly downregulated EPHB2 expression in a CRC cell model. To gain insights into the transcriptional regulation of EPHB2, potential cis-regulatory elements in the EPHB2 upstream region were analysed using reporter assays. A cell-type-specific enhancer was identified and subsequent chromatin analyses revealed a correlation between enhancer chromatin conformation and EPHB2 expression in different CRC cell lines. Additionally, the overexpression of the murine Snail1 induced chromatin changes at the EPHB2 enhancer towards a poised, transcriptionally silent chromatin conformation. Mutational analyses of the minimal enhancer region pinpointed three transcription factor binding motifs to be essential for full enhancer activity. Different binding patterns between CRC cell lines at the TCF/LEF motif were subsequently identified. Furthermore, a switch from TCF7L2 to LEF1 occupancy was found upon overexpression of Snail1 in vitro and in vivo. The generation of LS174T CRC cells overexpressing LEF1 confirmed the involvement of LEF1 in the downregulation of EPHB2 and the competitive displacement of TCF7L2. This part of the work demonstrated that the SNAIL1 induced downregulation of EPHB2 is dependent on the decommissioning of a transcriptional enhancer and led to a hypothetical model involving LEF1 and ZEB1.
In summary, this work highlighted two distinct mechanisms for enhancer regulation. One mechanism is based on enhancer repressive LINE fragments that might prevent stimulus-dependent enhancer activation. In the second, enhancer silencing was shown to be based on a competitive transcription factor binding mechanism.